[1] Phillips MI, Tang YL, Pinkemell K. Stem cell therapy for heartfailure:the science and current progress. Future Cardiol. 2008;4(3):285-298.[2] Wang JS, Shum TD, Galipeau J, et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages, J Thorac Cardiovasc Surg.2000;120(5): 999-1005.[3] Abarbanell AM, Coffey AC, Fehrenbacher JW, et al. Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart. Ann Thorac Surg. 2009; 88(3): 1036-1043.[4] Shake JG, Gruber PJ, Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg.2002;73: 1919-1925.[5] Zhou BY, Yang JH, Hui J, et al. Zhonghua Chaosheng Yingxiangxue Zazhi.2006;15(7):549-550. 周炳元,杨俊华,惠杰,等.经胸超声心动图评估介入栓塞法猪心肌梗死模型[J].中华超声影像学杂志,2006,15(7):549-550.[6] Lian F, Zhu HS, Zhu W, et al. Isolation, culture and identification of porcine bone marrow mesenchymal stem cells and transformation to myogenic cells in vitro. Shanghai Laboratory Animal Science.2003;23(2):67-69.[7] Armiñán A, Gandía C, García-Verdugo JM.Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells. J Cardiovasc Transl Res. 2010;3(1):61-65. [8] Tolmachov O,Ma YL,Themis M,et al,Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myoeytes in vitro[J].BMC Cardiovasc Disord.2006;6(6):25.[9] Zebedin E,Mille M,Speiser M,et al,C2C12 skeletal muscle cells adopt cardiac like sodium cttrrent properties in a cardiac cell environment.Am J Physiol Heart Circ Physiol.2007; 292(1): H439-50.[10] Tang YL, Zhao Q, Zhang YC, et al. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept. 2004;117:3-10.[11] Gersbach CA,Le Doux JM,Guldberg RE,et al.Inducible regulation of Runx2-stimulated osteogenesis. Gene Ther. 2006;13:873-882.[12] Kanellakis P,Slater NJ,Du XJ,et al.Granulocyte colony stimulating factor and stem cell factor im prove endogenous repair after myocardial infarction.Cardiovasc Res.2006;70(1): 117-125. [13] Orlic D,Kajstura J,Chimenti S,et al. Mobilized bone marrow cells repair theinfracted heart,improving function and survival. Proc Natl Acad Sci.2001;98: 10344-10349. [14] Askari AT,Unzek S,Popovic ZB,et al.Effect of stromal-cell-derived factor 1 ons tem-cell homing and tissue regeneration in Ischaemic cardiomyopathy. Lancet.2003; 362(9385):697-703.[15] Kutschka I,Kofidis T,Chen IY,et al.Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts. Circulation.2006;114(1 Supp1): 1174-1180.[16] Young-sup Yoon, Andrea Wecker, Lindsay Heyd, et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest. 2005, 115: 326-338.[17] Le Blanc K, Samuelsson H, Gustafsson B, et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia. 2007; 21(8):1733-1738.[18] Liu D, Si H, Reynolds KA, et al. Dehydro epiandro sterone vascular ndothelial cells against apoptosis Protects through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology. 2007;148(7):3068-3076.[19] Ryan JM,Barry F,Murphy JM,et al.Interferon does not break,but promotes the immunaanppressive capacity of adult human mesceils.Clin Immunol.2007;149(2):353-363.[20] Wang Y, Johnsen HE, Mortensen S, et al.Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention,Heart.2006; 92(6): 768 - 774.[21] Zhang M,Mal N,Kiedrowski M,et al.SDF-l expression by mesenchyrnal stem cells results in trophie support of cardiac myocytes after myocardial infarction.FASEB J. 2007;21(12): 3197-207. |